LARGE / MID-CAP BIOPHARMA

DAIICHI SANKYO (4568)

Tokyo, Japan · Europe
LARGE / MID-CAP BIOPHARMA
HEADQUARTERS
Tokyo, Japan
TICKER
4568
SEGMENT
Large / Mid-cap Biopharma
THERAPY AREAS
KEY PRODUCTS
PRODUCTDETAILS
Vanflyta
Turalio
Enhertu
Datopotamab deruxtecan Daiichi Sankyo
Nustendi

DAIICHI SANKYO — FULL INTELLIGENCE

Live regulatory signals, patent cliffs, financials, tariff exposure and pipeline — all free on PharmaSignal.

OPEN PLATFORM →